Release Date: 28/02/13 14:30 Summary: Appendix 4D and Interim Financial Report Price Sensitive: Yes Download Document 1.58MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%